Sonali P. Barwe

1.6k total citations
66 papers, 1.1k citations indexed

About

Sonali P. Barwe is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Sonali P. Barwe has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 28 papers in Hematology and 17 papers in Oncology. Recurrent topics in Sonali P. Barwe's work include Acute Myeloid Leukemia Research (24 papers), Ion Transport and Channel Regulation (13 papers) and CAR-T cell therapy research (11 papers). Sonali P. Barwe is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Ion Transport and Channel Regulation (13 papers) and CAR-T cell therapy research (11 papers). Sonali P. Barwe collaborates with scholars based in United States, India and Germany. Sonali P. Barwe's co-authors include Anilkumar Gopalakrishnapillai, Ayyappan K. Rajasekaran, Sigrid A. Rajasekaran, E. Anders Kolb, Julian P. Whitelegge, Yi Zheng, Sun Young Moon, Sergey Ryazantsev, Robert W. Mason and Daniel Wolle and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Sonali P. Barwe

65 papers receiving 1.1k citations

Peers

Countries citing papers authored by Sonali P. Barwe

Since Specialization

Citations

This map shows the geographic impact of Sonali P. Barwe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonali P. Barwe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonali P. Barwe more than expected).

Fields of papers citing papers by Sonali P. Barwe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonali P. Barwe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonali P. Barwe. The network helps show where Sonali P. Barwe may publish in the future.

Co-authorship network of co-authors of Sonali P. Barwe

This figure shows the co-authorship network connecting the top 25 collaborators of Sonali P. Barwe. A scholar is included among the top collaborators of Sonali P. Barwe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonali P. Barwe. Sonali P. Barwe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway 2025 ·Nature Communications ·(unknown), Hua Jiang, (unknown), (unknown), Hong-Fen Guo, Maegan L. Capitano, John Wrangle, (unknown), Anilkumar Gopalakrishnapillai, Santhosh Kumar Pasupuleti, Baskar Ramdas, Reuben Kapur, Sonali P. Barwe, Nai‐Kong V. Cheung, Sophie Paczesny	1
2	Bone Marrow Microenvironment-Induced Chemoprotection in KMT2A Rearranged Pediatric AML Is Overcome by Azacitidine–Panobinostat Combination 2023 ·Cancers ·(unknown), Anilkumar Gopalakrishnapillai, E. Anders Kolb, Sonali P. Barwe	1
3	Tetraspanins set the stage for bone marrow microenvironment–induced chemoprotection in hematologic malignancies 2023 ·Blood Advances ·(unknown), Anilkumar Gopalakrishnapillai, Sonali P. Barwe	3
4	Down syndrome and leukemia: An insight into the disease biology and current treatment options 2023 ·Blood Reviews ·Sonali P. Barwe, E. Anders Kolb, Anilkumar Gopalakrishnapillai	1
5	Imetelstat Induces Leukemia Stem Cell Death in Pediatric Acute Myeloid Leukemia Patient-Derived Xenografts 2022 ·Journal of Clinical Medicine ·Sonali P. Barwe, Fei Huang, E. Anders Kolb, Anilkumar Gopalakrishnapillai	14
6	Mesothelin: An Immunotherapeutic Target beyond Solid Tumors 2022 ·Cancers ·(unknown), (unknown), E. Anders Kolb, Anilkumar Gopalakrishnapillai, Sonali P. Barwe	54
7	Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of GATA1 and STAG2 Mutations in Induced Pluripotent Stem Cells with Trisomy 21 2022 ·Cells ·Sonali P. Barwe, Aimy Sebastian, (unknown), E. Anders Kolb, Anilkumar Gopalakrishnapillai	9
8	Efficacy of Flotetuzumab in Combination with Cytarabine in Patient-Derived Xenograft Models of Pediatric Acute Myeloid Leukemia 2022 ·Journal of Clinical Medicine ·Sonali P. Barwe, Anne Kisielewski, Ezio Bonvini, John Muth, Jan Davidson‐Moncada, E. Anders Kolb, Anilkumar Gopalakrishnapillai	4
9	Imetelstat Significantly Reduces Leukemia Stem Cells in Patient-Derived Xenograft Models of Pediatric AML 2021 ·Blood ·Sonali P. Barwe, Fei Huang, E. Anders Kolb, Anilkumar Gopalakrishnapillai	1
10	A 3-D hydrogel based system for hematopoietic differentiation and its use in modeling down syndrome associated transient myeloproliferative disorder 2021 ·Biomaterials Science ·(unknown), Sonali P. Barwe, Kristi L. Kiick, E. Anders Kolb, Anilkumar Gopalakrishnapillai	5
11	Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies 2021 ·Cancers ·Anilkumar Gopalakrishnapillai, Colin Correnti, (unknown), (unknown), (unknown), Ashok D. Bandaranayake, Christopher Mehlin, Anne Kisielewski, (unknown), Allison Kaeding, Soheil Meshinchi, James M. Olson, E. Anders Kolb, Sonali P. Barwe	6
12	Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies 2021 ·Cells ·(unknown), Sonali P. Barwe, Raju Pillai, Anilkumar Gopalakrishnapillai	3
13	Strong concordance between RNA structural and single nucleotide variants identified via next generation sequencing techniques in primary pediatric leukemia and patient-derived xenograft samples 2020 ·Genomics & Informatics ·Sonali P. Barwe, (unknown), Nitin Mahajan, Todd E. Druley, E. Anders Kolb, Erin L. Crowgey	2
14	Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology 2020 ·Molecular Therapy — Methods & Clinical Development ·Sonali P. Barwe, (unknown), E. Anders Kolb, Anilkumar Gopalakrishnapillai	13
15	CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia 2020 ·Blood Advances ·(unknown), Anilkumar Gopalakrishnapillai, E. Anders Kolb, Sonali P. Barwe	17
16	Error-corrected sequencing strategies enable comprehensive detection of leukemic mutations relevant for diagnosis and minimal residual disease monitoring 2020 ·BMC Medical Genomics ·Erin L. Crowgey, Nitin Mahajan, Winghing Wong, Anilkumar Gopalakrishnapillai, Sonali P. Barwe, E. Anders Kolb, Todd E. Druley	14
17	Mesothelin Is a Novel Disease Marker and Potential Therapeutic Target in Pediatric Acute Myeloid Leukemia 2017 ·Blood ·Allison Kaeding, Katherine Tarlock, Sonali P. Barwe, (unknown), Todd A. Alonzo, Robert B. Gerbing, Michael R. Loken, Rhonda E. Ries, Laura Pardo, Cassie Chou, E. Anders Kolb, Soheil Meshinchi	1
18	Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia 2017 ·Leukemia Research ·(unknown), Anilkumar Gopalakrishnapillai, Sonali P. Barwe	8
19	Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2 2007 ·International Journal of Oncology ·Neil H. Bander, Ayyappan K. Rajasekaran, David M. Nanus, James H. Keen, (unknown), Peter S. McPherson, Brigitte Ritter, Sonali P. Barwe, Oscar B. Goodman	28
20	Novel Role for Na,K-ATPase in Phosphatidylinositol 3-Kinase Signaling and Suppression of Cell Motility 2004 ·Molecular Biology of the Cell ·Sonali P. Barwe, Anilkumar Gopalakrishnapillai, Sun Young Moon, Yi Zheng, Julian P. Whitelegge, Sigrid A. Rajasekaran, Ayyappan K. Rajasekaran	134

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact